Vivanco Gruppe AG (VG0K) - Net Assets
Based on the latest financial reports, Vivanco Gruppe AG (VG0K) has net assets worth €-5.35 Million EUR (≈ $-6.26 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€17.70 Million ≈ $20.69 Million USD) and total liabilities (€23.05 Million ≈ $26.95 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Vivanco Gruppe AG liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-5.35 Million |
| % of Total Assets | -30.25% |
| Annual Growth Rate | N/A |
| 5-Year Change | -208.77% |
| 10-Year Change | N/A |
| Growth Volatility | 697.32 |
Vivanco Gruppe AG - Net Assets Trend (2013–2024)
This chart illustrates how Vivanco Gruppe AG's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Vivanco Gruppe AG for the complete picture of this company's asset base.
Annual Net Assets for Vivanco Gruppe AG (2013–2024)
The table below shows the annual net assets of Vivanco Gruppe AG from 2013 to 2024. For live valuation and market cap data, see market value of Vivanco Gruppe AG.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €-5.35 Million ≈ $-6.25 Million |
-1999.99% |
| 2023-12-31 | €281.59K ≈ $329.21K |
-92.40% |
| 2022-12-31 | €3.70 Million ≈ $4.33 Million |
-12.38% |
| 2021-12-31 | €4.23 Million ≈ $4.94 Million |
-14.05% |
| 2020-12-31 | €4.92 Million ≈ $5.75 Million |
-7.45% |
| 2019-12-31 | €5.31 Million ≈ $6.21 Million |
+10.43% |
| 2018-12-31 | €4.81 Million ≈ $5.63 Million |
+52.89% |
| 2017-12-31 | €3.15 Million ≈ $3.68 Million |
+224.79% |
| 2016-12-31 | €-2.52 Million ≈ $-2.95 Million |
+69.73% |
| 2015-12-31 | €-8.33 Million ≈ $-9.74 Million |
+10.88% |
| 2014-12-31 | €-9.35 Million ≈ $-10.93 Million |
+8.33% |
| 2013-12-31 | €-10.20 Million ≈ $-11.93 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Vivanco Gruppe AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 449771692.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €32.77 Million | % |
| Total Equity | €-5.35 Million | 100.00% |
Vivanco Gruppe AG Competitors by Market Cap
The table below lists competitors of Vivanco Gruppe AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Brain+ ApS
CO:BRAINP
|
$744.48K |
|
REVITALIST L.A.W. LTD
F:4DO
|
$744.60K |
|
National World PLC
LSE:NWOR
|
$745.78K |
|
Norrland Gold Corp
V:NORR
|
$746.53K |
|
Colefax Group
LSE:CFX
|
$741.63K |
|
Ondine Biomedical Inc
LSE:OBI
|
$741.08K |
|
ALGERNON PHARMACEUT. A
F:AGW0
|
$740.91K |
|
Maven Income And Growth Vct 5 Plc
LSE:MIG5
|
$740.77K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vivanco Gruppe AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 229,272 to -5,350,126, a change of -5,579,398 (-2433.5%).
- Net loss of 6,981,294 reduced equity.
- Other factors increased equity by 1,401,896.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-6.98 Million | -130.49% |
| Other Changes | €1.40 Million | +26.2% |
| Total Change | €- | -2433.53% |
Book Value vs Market Value Analysis
This analysis compares Vivanco Gruppe AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.58 | €0.14 | x |
| 2018-12-31 | €0.89 | €0.14 | x |
| 2019-12-31 | €0.98 | €0.14 | x |
| 2020-12-31 | €0.87 | €0.14 | x |
| 2021-12-31 | €0.75 | €0.14 | x |
| 2022-12-31 | €0.66 | €0.14 | x |
| 2023-12-31 | €0.04 | €0.14 | x |
| 2024-12-31 | €-0.97 | €0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vivanco Gruppe AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27.16%
- • Asset Turnover: 1.08x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-104.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -3.51% | 1.22x | 0.00x | €-1.59 Million |
| 2014 | 0.00% | 1.39% | 1.52x | 0.00x | €2.14 Million |
| 2015 | 0.00% | 1.06% | 1.55x | 0.00x | €1.76 Million |
| 2016 | 0.00% | 8.33% | 1.54x | 0.00x | €7.22 Million |
| 2017 | 195.24% | 7.84% | 1.45x | 17.16x | €5.97 Million |
| 2018 | 44.23% | 2.79% | 1.51x | 10.48x | €1.68 Million |
| 2019 | 19.40% | 1.30% | 1.41x | 10.62x | €508.85K |
| 2020 | -6.06% | -0.45% | 1.06x | 12.66x | €-769.65K |
| 2021 | -16.39% | -1.39% | 0.93x | 12.75x | €-1.09 Million |
| 2022 | -13.81% | -1.05% | 1.04x | 12.65x | €-861.70K |
| 2023 | -1472.69% | -8.99% | 1.12x | 145.68x | €-3.40 Million |
| 2024 | 0.00% | -27.16% | 1.08x | 0.00x | €-6.45 Million |
Industry Comparison
This section compares Vivanco Gruppe AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vivanco Gruppe AG (VG0K) | €-5.35 Million | 0.00% | N/A | $743.68K |
| Covestro AG (1COV) | $5.37 Billion | 37.45% | 1.11x | $11.10 Billion |
| 2invest AG (2INV) | $84.50 Million | 65.13% | 0.01x | $70.69 Million |
| Adaptimmune Therapeutics plc (473A) | $81.88 Million | -202.08% | 3.02x | $42.94 Million |
| Biotest Aktiengesellschaft (BIO) | $412.30 Million | -20.01% | 1.33x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $360.70 Million | -12.70% | 1.59x | $656.94 Million |
| Bancolombia S.A (BXK) | $26.66 Trillion | 9.98% | 7.26x | $4.84 Billion |
| mVISE AG (C1V) | $14.00K | -24457.14% | 623.71x | $10.43 Million |
| pferdewetten.de AG (EMH) | $16.37 Million | -0.96% | 1.09x | $8.43 Million |
| HAMMONIA Schiffsholding AG (HHX) | $60.71 Million | 8.40% | 0.05x | $38.20 Million |
| Ernst Russ AG (HXCK) | $51.09 Million | 12.17% | 1.02x | $235.15 Million |
About Vivanco Gruppe AG
Vivanco Gruppe AG engages in the development, procurement, and supply of equipment and connection accessories for consumer electronics, information technology, and telecommunication industries in Germany, rest of Europe, and internationally. Its products comprise smartphone accessories, including bags and sleeves, screen protectors, chargers, cables and adapters, mountings, and earphones and head… Read more